Reuters logo
BRIEF-Cycle Pharmaceuticals gets FDA approval for Ketorolac Tromethamine injection
September 19, 2017 / 2:44 PM / a month ago

BRIEF-Cycle Pharmaceuticals gets FDA approval for Ketorolac Tromethamine injection

Sept 19 (Reuters) - Cycle Pharmaceuticals:

* Cycle Pharmaceuticals receives FDA approval and launches Ketorolac Tromethamine injection 30mg/ml in the U.S.

* Cycle Pharmaceuticals receives FDA approval and launches Ketorolac Tromethamine injection 30mg/ml in the U.S. Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below